Investing Moderna, Merck Shares Soar on Cancer Vaccine Trial Success Finance News Aug 20, 2026 An experimental personalized mRNA vaccine developed by Moderna (NASDAQ:MRNA) and Merck & Company (NYSE:MRK)… Read More...
Investing Eli Lilly Cancer Drug Wins FDA Breakthrough Therapy Status Finance News Aug 4, 2026 The US Food and Drug Administration (FDA) granted Breakthrough Therapy designation to Eli Lilly and Company's… Read More...
Finance Eli Lilly to Buy Psychedelics Firm AtaiBeckley for US$2.8 Billion Finance News Jul 18, 2026 Pharmaceutical giant Eli Lilly and Company (NYSE:LLY) is pushing further into the psychedelic drug market with a… Read More...
Investing Government approvals secured for the use of Galidesivir as a treatment for Finance News Jul 7, 2026 Australian antiviral drug development company, Island Pharmaceuticals Ltd (ASX: ILA; Island or the Company) is… Read More...
Investing Merck KGaA to Acquire Bio-Techne in US$11.3 Billion Deal Finance News Jun 27, 2026 Merck KGaA (ETR:MRK,OTCPL:MKGAF) has agreed to acquire life sciences supplier Bio-Techne (NASDAQ:TECH) for US$11.3… Read More...
Investing BriaCell Therapeutics: Redefining Oncology with Personalized Cancer Finance News May 11, 2026 BriaCell Therapeutics (TSX:BCT,NASDAQ:BCTX) is a clinical-stage immuno-oncology company focused on transforming… Read More...
Finance Seegnal Inc. Establishes Strategic Commercialization Team and Appoints Arx Finance News Apr 4, 2026 Seegnal Inc. (TSXV: SEGN) ("Seegnal" or the "Company"), a global leader in clinical decision support solutions… Read More...
Investing Inside the ASX Biotech Boom: What’s Fuelling the Next Wave Finance News Jan 1, 2026 Australia’s healthcare and biotechnology sector has matured into one of the most promising and strategically… Read More...
Investing InMed Pharmaceuticals: Innovating Cannabinoid-inspired Medicines, Backed by Finance News Nov 11, 2025 InMed Pharmaceuticals (NASDAQ: INM) pairs innovative therapeutic development in Alzheimer’s, ophthalmology, and… Read More...
Finance New Deal Could Spark Invion’s Entry into Pet Cancer Market, CEO Says Finance News Oct 30, 2025 Invion’s (ASX:IVX,OTC Pink:IVIXF) Photosoft cancer treatment technology has entered an important milestone, thanks to… Read More...